跳至主要内容
临床试验/CTRI/2023/10/058318
CTRI/2023/10/058318招募中Unknown

Evaluate the efficacy of Indian Ayurvedic Formulation Aurogrit in subjects with Breast Cancer: A Single-Arm, Open-Label, Prospective, Interventional Study - NI

Patanjali Research Foundation governed by Patanjali Research Foundation Trust0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Subjects diagnosed with Breast Cancer.
  • Subjects Aged 18 years and above.
  • Willing to participate and give consent for the study.
  • Capability for complete compliance and completion of follow-up

排除标准

  • Male subjects with breast cancer.
  • Subjects diagnosed with Metastatic breast cancer.
  • Subjects with other co-morbidities, such as CVD, liver abnormalities, and HIV.
  • Assessment by the investigator as being unable or unwilling to comply with the requirements of the protocol.
  • The subjects with complications and requiring surgical interventions.
  • Pregnant or Lactating women and women intenting to become pregnant

研究者

发起方
Patanjali Research Foundation governed by Patanjali Research Foundation Trust

相似试验